(-)-Epigallocatechin, Antioxidant activity
Be the first to review this product! Submit a review
|
(0 Publication)
- Larger volume format available upon request.
- Chemical Structure
Lab
Chemical Structure - (-)-Epigallocatechin, Antioxidant activity (AB142378)
2D chemical structure image of ab142378, (-)-Epigallocatechin, Antioxidant activity
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Handling instructions
Need more advice on solubility, usage and handling? Please visit our our product support page for more details.
|
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Opioid receptors are integral to the modulation of pain and reward systems. They exist as monomers or dimers and can form higher-order complexes with each other or with other GPCRs to influence signal transduction pathways. When activated by their ligands they inhibit cyclic adenosine monophosphate (cAMP) production which reduces neuronal excitability. By interacting with ligand molecules like herkinorin dermorphin and Mu agonists these receptors contribute to the analgesic and euphoric effects typical of opioid ligands.
Pathways
Delta Kappa and Mu receptors play key roles in the endogenous opioid signaling pathways and the dopaminergic reward pathway. These pathways influence neurotransmitter release and neuronal activity often associated with the sensation of pain relief and reward. The dopaminergic pathway also involves proteins like the dopamine transporter protein which works alongside these opioid receptors to regulate dopamine levels in synaptic clefts. Opioid antagonists like naloxone interact with these pathways by blocking the opioid receptors to reverse opioid-induced effects.
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com